| Lightcalls.com |
|
|
![]() |
As post-war baby boomer reach their...As post-war baby boomer reach their 50 many are interested in using the business knowledge they've acquired in their careers and taking upon the responsibility of joining a board of directors. As the business world becomes more challenging and complexus this wealth of talent is long needed, yet few candidates completely understand the role of a board member or what it takes to make a prosperous contribution. To make matters worse, those who do have a better idea of what's required may be in such a manner daunted by the current lack of investor confidence in board practices, that-after weighing the risks versus the rewards of sitting onward a board-they're choosing to pass. The message here? If you're common of the ones still looking to join a board, a certain number of due diligence is definitely in order. Revisiting Corporate Governance "101" If you search the Internet using "corporate board" or "board of directors" as your parameters, you'll find a variety of resources, including parts and subscriber newsletters (one of my favourite works on the subject is Ralph Ward's Improving Corporate Boards). Unfortunately however, small in number prospective or existing board members through all ages choose to fully study these kinds of materials, and as a deduction few boards conduct their meetings following well-researched "good practices." Why? In many cases, it's simply a matter of mathematics. A board member acquires paid $x and is calculate uponed to attend an average of 6 to 10 meetings by year. If they also sit onward sub-committees such as audit, compensation, or compliance, extra days or part days are added to the proces In names of additional preparation time, a board member may decide that the compensation propounded justifies nothing more extensive than the reading of materials en path to each board meeting. Many board members will gainsay this, but detailed interviews with directors indicate that minimal preparation is commonplace. In order to understand on what account this lack of preparation and research is in such a manner dangerous, we need to understand the basic part of corporate governance. Simply place the board of directors is present in place to represent the shareholders' best interests. by the agency of the efforts of the chairman, the board's goal is to make sure that the management team, personateed on the board by the CEO has a plan, and is executing to this plan. unimpaireds simple and orderly, yet many boards don't function this way. If they did, there would be no question of CEO serving as chairpersons, because according to this simple premise, a CEO doubling as chairman shows an absolute conflict of interest. We're fortunate in Canada to have many fine examples of corporate governance done right. The Royal Bank of Canada, for example, stands not at home as an excellent example of useful governance practices. Its board chairman is independent and takes his part very seriously; the board adapteds without the CEO present for part of each meeting; and each year, board members are asked to rate the contributions made according to fellow members. Each one of these stairs demonstrates a highly effective, no-nonsense approach. Asking the right questions So the first series of questions you ne to ask relate to the effectiveness of the board. * What is the board structure? * Is the board independent from the CEO? * Does the board sooth to say supervise the CEO? * in what way many outside directors are portray by actioned on the board? * Is there a specific manner [i]or[/i] principle of holding for board members? * Is there a do job-work description for board members? * Does the company use a nominating committee comprised of characters other than management to identify, sieve and propose new board member candidates? * What attributes are considered essential for prospective board members? Is specific industry knowledge and experience required? * What are the skills and attributes of existing board members? * to what extent often does the board meet? Once you have an idea of the board's composition, you might want to design a small questionnaire for existing board members. Questions could include the following: * to what extent long have you been a member of the board? * What was your prior relationship with management (if any)? * to what degree much time do you usually expend preparing for a meeting? * by what means effective have the meetings been? * by what means are you making a difference? * Do you believe you can impact the stewardship of the company? * Does a state of mutual trust exist in which management and the board communicate candidly and honestly? Contact each board member and ask for 15 minutes of their time to ask them these questions. This proces minister tos many purposes; for instance, it enables you to learn a feel for the quality and dedication of the other board members, and to demonstrate your intention to take your part seriously and handle matters professionally. one time you've conducted your interviews, you should arrange to come up to face to face with the CEO face-to-face. Share your findings, and ask the CEO the same questions. It would also be helpful for you to talk with the CFO to determine the protoplast and timing of information made available to board members. Experience point outs that many directors face common of two challenges: either having far too little information to gain a exact perspective on a company's financial health, or being snowed subordinate to by too much information. A smart board repeatedly starts with a smart CFO-one who nears materials that reflect the veracious picture of how the company is performing to plan. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |